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ABSTRACT
Introduction: Hepatitis C virus (HCV) infection is known as contributing to high morbidity and mortality globally. 
Major liver complications such as liver failure and liver cancer which can lead to fatality have been associated with 
persistent HCV infection. Globally, it is estimated that 5.6 million chronically infected HCV are among people who 
inject drugs (PWID). Malaysia has estimated that 59% HCV infections were among PWID. The aim of this study 
is to determine the prevalence of HCV infection and its predictors among PWID in Negeri Sembilan. Methods: A 
cross-sectional study based on random proportion to size sampling was conducted among 212 out of 1414 regis-
tered Methadone Maintenance Therapy (MMT) clients with PWID attending health clinics in Negeri Sembilan from 
February 2018 to July 2018. Data were collected using questionnaires administered through face-to-face interviews. 
Data were analyzed using Statistical Package of IBM SPSS Statistics Version 23 and p-value of <0.05 is considered 
significant. Independent T test and Chi-square test(χ2) were used to determine the associations between the vari-
ables, and multiple logistic regressions for the predictors. Results: Majority of the respondents were infected with 
HCV infection (89%). HCV infection were associated with their age(p<0.001), low education level(p=0.022), HIV 
infection(p=0.001), and higher frequency(p=0.001) with longer duration(p=0.026) of drug injections and needle 
sharing(p=0.001). The predictors of HCV were older age [AOR 1.07, 95% CI(1.032, 1.110)] and higher frequency 
of injections[AOR 5.98, 95% CI(3.110,11.476)].   Conclusion: HCV infection is prevalent among PWIDs. Hence, 
effective and efficient preventive measures should be targeted to the identified predictors.      
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INTRODUCTION
Hepatitis C Virus (HCV) is an RNA virus derived from 
the Flaviviridae family (1). HCV can present as acute 
or chronic infections. In acute HCV infection, it is 
commonly asymptomatic, and infrequently associated 
with lethal outcomes (2). World Health Organization 
(WHO) stated that approximately 15% to 45% of 
HCV infection, without medical intervention, will 
be undergoing spontaneously clearance of HCV in a 
period of 6 months after the first infection. Meanwhile, 
about 60% to 80% of HCV infection will progress into 
chronic HCV infections whereby, the risk of developing 
Hepatocellular Carcinoma (HC) is 15% to 30% in a 
period of 20 years (3). It is known that the transmission 
of HCV is through blood borne and based on many 
studies, among PWIDs, the main transmission is through 
blood (4), while others are related to occupational 
hazards such as needle stick injury in medical field, 
sexually transmission and vertical transmission (5, 6, 7). 
Hepatitis C virus (HCV) infection is a global major 
leading cause of morbidity and mortality among PWID. 
Globally, it was estimated that 71 million PWIDs were 
infected with HCV in which 5.6 million were chronically 
infected (3, 8). According to Larney et al., (2015), PWID 
are those who have injected an illicit drug at least once 
in their lifetime. East and Southeast Asia and Eastern 
Europe contributed to the highest prevalence of HCV 
seropositive among PWID at 26% and 23% respectively 
(9). Moreover, there are still high numbers of PWID 
population in Latin America at 14% and Canada and the 
United States at 17% (10). HCV infection continues to 
increase and leading to higher morbidity and mortality 
among PWID.  According to Malaysia’s Health Facts 
between 2012 and 2016, there was an increased trend in 
both incidence rate and mortality rate of HCV infections 
from 5.91 per 100,000 population to 8.35 per 100,000 
population and 0.11 per 100,000 population to 0.13 
per 100,000 population respectively (11). Similarly, a 
study done by Raihan in 2016 stated that in Malaysia, 
approximately 2.5% of the adult population are infected 
with HCV of which 59% (95% CI: 50-68%) were infected 
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via injection practices. Thus, intensive prevention and 
control of HCV infection targeting PWID are needed to 
reduce further burden of HCV infection (12). 
According to the National Anti-Drug Agency (NADA), 
PWID are still high in developing countries, including 
Malaysia whereby the cumulative numbers of existing 
PWID are constantly higher by years (13). There were 
18, 217 drug users registered and arrested in the 
period between 1988 and 2015 in Negeri Sembilan 
(13).  Although there a comprehensive harm reduction 
program, the number of HCV infections among PWID 
continues to increase. In Negeri Sembilan, based on 
unpublished reports from Negeri Sembilan Weekly 
Epidemiology Review (NSWER), from 2016 to 2017, there 
are increased number of HCV infection from 227 cases 
(incidence of 26.7%) up to 365 cases (incidence of 35%) 
in 2017.  Meanwhile, mortality due to HCV infections 
among PWID was 23.8% in 2016 and 22.2% in 2017 
(14). There are many challenges related to PWID such 
as social vulnerabilities including low socioeconomic 
status, low education level, tendency to commit crimes, 
issues of discrimination and stigmatization hence their 
poor access to healthcare services (15, 16).
This study is aimed to determine the prevalence of HCV 
infection and its predictors among people who inject 
drugs in Negeri Sembilan. It hypothesizes that there are 
significant associations between HCV infection with 
sociodemographic factors, socioeconomic, high risk 
behavior and coinfections among PWID. A reliable local 
prevalence data and knowledge of its predictors are 
useful to ensure more appropriate preventive measures 
to reduce both mortality and mortality of HCV infection 
among PWID in studied area. 
MATERIALS AND METHODS
Study Design and Samples
This study was conducted in Negeri Sembilan; a state 
located at southern region Malaysia.  Based on the 
Department of Statistic Malaysia (DOSM), in 2015, the 
populations of Negeri Sembilan were 1.1 million.  In 
Negeri Sembilan, there were 4 out of 7 hospitals and 
32 out of  50 health clinics under the administration 
of Negeri Sembilan State Health Department (NSSHD) 
are  providing MMT services in view of high numbers 
of PWID in those area, adequate health facilities to 
deliver the services such as skilled and trained medical 
personnel, availability of methadone dispensaries 
during the treatment given. A cross sectional study 
was conducted, which involved MMT clients who 
were PWID and aged above 18 years old in selected 
government health facilities within Negeri Sembilan. 
The sample size (n) in this study was calculated by using 
the two proportions formula (Lwanga and Lemeshow, 
1990) making the final sample size of 212. The sampling 
frame of this study was taken from a list of cumulative 
numbers of registered MMT with PWID clients in health 
facilities for the whole 7 districts under the administration 
of Negeri Sembilan State Health Department. The 
individual number was assigned to each active MMT 
with PWID client in the study population based on 
the proportion of 212 (sample size) out of 1414 of the 
potential respondents (study population). The study 
samples were selected randomly using the SPSS program 
proportionate to each district. 
The list of independent variables in this study were as 
below:  
i. Sociodemographic factors: Age, Gender, Ethnicity, 
Marital status, Education level
ii. Socioeconomic factors: Employment, Household 
income
iii. High Risk Behaviors: Needle sharing, age of onset 
injecting drug, duration of injecting drug, frequency of 
injections, imprisonment, sexuality, sexual intercourse 
with sex worker
iv. Coinfections: Human Immunodeficiency Virus 
(HIV) & Hepatitis B Virus (HBV) 
The dependent variable was HCV infection among 
PWID who were active clients registered in MMT 
program under administration of Negeri Sembilan State 
Health Department. 
Study Measures
The study instrument was using both Performa and 
a validated questionnaire with face to face interview 
using Malay and English languages. Four sections 
in the questionnaire were consist of section 1 
(sociodemographic characteristics of the respondents), 
2 (socioeconomic characteristics of the respondents), 
3 (high risk behaviors), and 4 (HCV, HBV and HIV 
coinfections).  In section 1 and 2 the respondents were 
asked for their age, gender either ‘male’ or female’, 
ethnicity given several options including ‘Malay’ or 
‘Chinese’ or ‘Indian’ or ‘others’, marital status either ‘yes’ 
or ‘no’ and their highest level of education based on ‘no 
formal education’ or ‘primary education’ or ‘ secondary 
education’ or ‘tertiary education’. Meanwhile, in 
section 2, the respondents were asked for their current 
employment status either ‘yes’ or ‘no’ and household 
income in an open-ended column.  
Moreover, in section 3, the respondents were asked 
about their high-risk behavior which includes the 
respondents needle sharing, age of onset for injecting 
drug, duration of injecting drug, frequency of injecting 
drug, imprisoned and attempted sexual intercourse with 
sex workers. Needle sharing were asked for their history 
of needle sharing while injecting drugs among other 
PWID either ‘ yes’ or ‘no’, for Age of onset for injecting 
drug  the respondents were asked for their history related 
to the duration on injecting drug in open ended column, 
Frequency of injecting drug the respondents were asked 
regarding their history of last injections  either ‘more than 
once a day’ or ‘once a day’. Imprisoned were measured 
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by asking the respondents for history of incarceration 
due to drug abuse either ‘yes’ or ‘no’ and the history 
having sexual intercourse with any sex worker  was 
either ‘yes’ or ‘no’.  The Cohen’s kappa value in section 
3 was (0.717, α<0.001).
Besides, in section 4, all HCV, HBV and HIV result were 
retrieved based on a confirmatory laboratory result that 
were available in the clients’ manual medical records. 
HCV positive means the respondents’ positive PCR 
for HCV RNA result regardless acute or chronic HCV 
infection either ‘yes’ or ‘no’. For HBV positive means 
the respondents’ co-infections with positive HBsAg/anti-
HBc result regardless acute or chronic HCV infection 
either ‘yes’ or ‘no’.  Finally, for HIV positive means the 
respondents’ co infections with positive anti-HIV1/HIV2 
result regardless acute or chronic HCV infection. All 
three-blood screening were taken based on MMT client 
for baseline assessment prior to the program entrance. 
The instruments were further assessed by two expert 
physicians from the Public Health. The experts had 
assessed and gave feedbacks regarding the contents 
of the questionnaire. All the comments and the 
recommendations were taken into consideration. 
The back to back translations was constructed for 
the questionnaire by linguistic experts in English and 
Malay language. The pre-testing of the questionnaire 
was conducted among 23 MMT with PWID clients 
who came to health facilities in Negeri Sembilan. All 
the comments were taken for any necessary correction. 
Participants who were involved in the pre-testing were 
excluded from the study.  The test-retest reliability was 
measured by Cohen’s Kappa with the value at >0.7. 
Statistical Analysis
Data analysis utilized the IBM Statistical Analysis 
of Social Sciences System (SPSS) version 23.0. The 
descriptive analysis performed used percentage and 
frequencies in all variables studied. The chi square test 
is used to look for association in the categorical variable 
of both independent and the dependent variable. 
This study was using a significance level of 0.05 with 
confidence interval 95%. Thus, with the p value < 0.05, 
Null Hypothesis was rejected. Besides that, the multiple 
logistic regressions were run for the predictors of HCV 
infection on PWID. 
A multiple logistic regression was used to determine 
the predictors of HCV infection among PWID in Negeri 
Sembilan.  This analysis used three method which were” 
ENTER” method, “Forward LR” method, and “Backward 
LR” method to analyze the predictors. In this study, 
the “Backward LR” method produced the maximum 
significant variables which were two variables out of ten 
variables in the preliminary models.
Ethics approval and consent to participate
Ethical approval for this study was obtained from the 
Ministry of Health’s (MOH) Medical Research and 
Ethic Committee (MREC)(NMRR-18-271-39853) 
and Ethic Committee for Research Involving Human 
Subjects Universiti Putra Malaysia or Jawatankuasa 
Etika Universiti untuk Penyelidikan Melibatkan Manusia 
(JKEUPM). All the eligible respondents were given the 
written consent prior to the completion of the study.
RESULTS
A total of 212 face-to-face interview using questionnaire 
were conducted with eligible respondents based on 
inclusion and exclusion criteria. There were 212 
respondents who completed the questionnaire thus; 
the response rate was 100%. The normality testing 
was conducted to the continuous data such as the 
respondent age, age of onset for injections and duration 
on injections. In this study, the respondent age showed 
normal distribution according to visual evidence of 
histogram and significant value of Kolmogorov-Smirnov 
was 0.200 and Shapiro-Wilk was 0.249 (P>0.05). 
 
The Prevalence of HCV, HBV and HIV among PWID in 
Negeri Sembilan 
Table I shows the prevalence of HCV, HBV and HIV 
infections of the respondents. Among 212 respondents, 
89.0% of respondents were HCV positive, 27.9% 
were HBV positive and 7.1% HIV positive. All (100%) 
respondents have undergone infectious disease 
blood screening routine for HCV, HBV and HIV, with 
majority (91.5%) aware of their own infectious status. 
Unfortunately, only 10.4% had undergone treatment for 
HCV, HBV and/or HIV.
Table I: The Prevalence of HCV, HBV and HIV among PWID in Neg-
eri Sembilan (n=212) 
Characteristics n (%)
Hepatitis C Virus
No 82 (38.7)
Yes 130 (89.0)
Hepatitis B Virus
No 261 (72.1)
Yes 101 (27.9)
HIV
No 197  (92.7)
Yes 15
Ever been screened (7.1)
Yes 212 (100)
Ever known infectious status
No 18 (8.5)
Yes 194 (91.5)
Ever had any treatment (HCV/HIV/HBV)
No 190 (89.6)
Yes 22 (10.4)
Mal J Med Health Sci 16(1): 261-169, Jan 2020264
Malaysian Journal of Medicine and Health Sciences (eISSN 2636-9346)
Association between Sociodemographic/
Socioeconomic Characteristic and HCV Infection
There was significant difference between HCV infection 
and age.  Older PWID (Mean=44.38, SD= 8.586) was 
at higher risk to developed HCV infection as compared 
to younger PWID (Mean=39.41, SD=9.319), t (210) 
=-3.964, p<0.001.  Moreover, this study also found 
that HCV infection and lower education level was 
significantly associated (χ2= 5.221, df = 1, p= 0.022). 
HCV infection was higher among those who have 
lower educational level (85.0%) than those who have 
higher educational level (58.9%). However, marital 
status, ethnicity, employment status and household 
income were not associated with HCV infection. Table 
II shows the association between sociodemographic/
socioeconomic and HCV infection. 
Table II: Association between sociodemographic and socioeconomic 
characteristics and HCV infection (N=212)
Variables Present 
of HCV 
Infections
n = 130(%)
Absent 
off HCV 
Infections
n = 82 (%)
t / X2 df P-value
Age group
Mean ± SD 44.38 ± 
8.586
39.41 ± 
9.319
-3.964 210 <0.001*
Marital status
Unmarried 58(59.8) 39 (40.2) 0.176 1 0.777
Married 72 (62.6) 43 (37.4)
Education
Lower Education 17(85.0) 3(15.0) 5.221 1 0.022*
Higher Education 113(58.9) 79 (41.1)
Ethnicity
Non-Malay 15(71.4) 6 (28.6) 1.004 1 0.316
Malay 115(60.2) 76 (39.8)
Employment
Unemployed 18(78.3) 5 (21.7) 3.121 1 0.077
Employed 112(59.3) 77 (40.7)
Household Income
Lower Income 39(69.6) 17(30.4) 2.222 1 0.136
Higher Income 91(58.3) 65(41.7)
* Significant at P < 0.05
Table III: Association between High Risk Behavior Characteristics 
and HCV Infections (N=212)
Variables
Present 
of HCV 
Infections
Absent 
of HCV 
Infections
Test Statistics
n = 130 (%) n = 82 (%) X2 df P-value
Age First   injection
<25 yrs. 93(60.8) 60(39.2) 0.067 1 0.798
≥25yrs 37(62.7) 22(37.3)
Duration of injections in years
≤2yr 12(48.0) 13(52.0) 9.261 3 0.026*
3-5yrs 13(41.9) 18(58.1)
6-10yrs 24(22.7) 13(35.1)
>10 yrs. 81(73.0) 38(46.0)
Frequency of injections
More than once a day 106(74.6) 36 (25.4) 32.204 1 0.001*
Once a day 24(34.4) 46 (65.7)
Ever shared needle
No 68 (47.6) 75 (52.4) 35.115 1 0.001*
Yes 62 (89.9) 7 (10.1)
Ever had sex with sex workers
No 116(62.24) 70 (37.6) 0.698 1 0.403
Yes 14(53.8) 12 (46.2)
Ever Imprisoned
No 17(48.6) 18 (51.1) 2.873 1 0.09
Yes 113(63.8) 64 (36.2)
* Significant at P < 0.05
Table IV: Association between HBV/HIV and HCV coinfections
Variables
Present 
of HCV 
Infections
n = 
130(%)
Absent 
off HCV 
Infections
n = 82 
(%)
Test Statistics
X2 df P-value
Hepatitis B Virus
No 126(60.9) 81(39.1) 0.753 1 0.651
Yes 4(80.0) 1(20.0)
HIV
No 115(58.4) 82 (41.6) 10.182 1 0.001*
Yes 15(100) 0(0)
* Significant at P < 0.05
Association between High Risk Behavior Characteristics 
and HCV Infections 
There were significant association between duration of 
injections and HCV infections (χ2= 9.261, df = 3, p= 
0.026). Those who have been injecting drugs longer 
than 10 years are more likely to develop HCV infection 
as compared to those injecting shorter than 10 years 
duration. Moreover, the frequency of injection and HCV 
infections is also significantly associated (χ2= 32.204, 
df = 1, p= 0.001). Besides, there was also significant 
association between needle sharing behavior and 
HCV infection (χ2= 35.115, df = 1, p= 0.001).  Table 
III shows the association between high risk behavior 
characteristics and HCV infection.
Association between HBV, HIV and HCV Coinfections 
among PWID (N=212)
There were significant association between HIV 
coinfections with HCV among PWID in Negeri Sembilan 
(X2= 10.182, df = 1, p= 0.001) but not to HBV (χ2= 
0.753, df = 1, p= 0.651). In this study, all HIV infected 
PWID were also infected with HCV infections. Table 
IV shows the association between HBV, HIV and HCV 
coinfections among the respondents. 
The Predictors of HCV Infection 
The reference group for frequency of injections was at 
once a day. The full model containing all predictors 
was statistically significant at (χ2= 46.785, df = 2, 
p=<0.001) which indicating that the model was able 
to distinguish between the significant associated factors 
with HCV among PWID.  This model also fit the sample 
as shown by Hosmer and Lemeshow goodness of fit 
test (χ2= 13.833, df = 8, p=0.086). The predictors in the 
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model explained 26.9% of the total variance in HCV 
infection among PWID attending health facilities in 
Negeri Sembilan (Nagelkerke R2= 0.269). The model is 
correctly classified about 74.1%. In this study, a year 
increase in age increase odds of HCV by 1.07 times, 
while controlling for frequency (AOR=1.0, 95% CI 
1.032-1.110). Furthermore, respondents who were 
frequently injecting more than once a day are 5.975 
times more likely infected with HCV in contrast with 
those who were injecting once a day (AOR= 5.975 95% 
CI 3.110-11.476) (Table V). 
Table V. Predictors of HCV Infection among PWID
Variable β SE Wald P - 
value
Adjusted 
Odds 
Ratio
(95% CI)
Upper Lower
Age  0.068 0.019 13.256 <0.001* 1.070 1.032 1.110
Frequency of injections
More than 
once a day
1.788 0.333 28.809 <0.001* 5.975 3.110 11.476
Constant -3.519 0.843 17.413 0.000 0.030
*Significant at P <0.05
The final predictive model derived from the multiple 
logistic regression analysis is shown below:
Log (probability HCV infection) = -3.519+ (0.068) (age) 
+ (1.788) (frequency of injection more than once a day)
The log (probability of HCV infection is equal to -3.519 
(constant) in addition of 0.068 low risk by increasing 
age and 1.788 more likely contracting HCV infection if 
the frequency injecting is more than once daily among 
those PWID.
DISCUSSION
Prevalence of HCV, HBV and HIV among PWID
People who injects drug (PWID) remains as a major 
worldwide health challenge as they contribute to the 
blood borne transmission of infections such as HIV and 
HCV (3). It was estimated that 23% out of 1.7 million 
incidence of HCV globally in 2015 were related to drug 
injecting practices among PWID (3, 17-18, 19). This study 
found that the prevalence of HCV infection was 89.0% 
among the respondents. Meanwhile, prevalence of HBV 
and HIV infection were 27.9% and 7.1% respectively. 
These findings are similar with a study done in China 
where 71.1% of PWID were infected with HCV (20). 
It shows that HCV infections are at higher prevalence 
among PWIDs which may be due to unsafe injecting 
practices which has been known to be the main route 
of transmission of HCV (20, 21).  Moreover, PWID 
distributions are still high in most developing countries 
including Malaysia whereby the cumulative numbers of 
existing PWID are constantly higher by years (13). A few 
studies have also identified that PWID are facing a lot of 
social vulnerabilities such as low socioeconomic status, 
low education, prone to commit crimes, and issues 
of discrimination and stigmatization resulting in poor 
access to healthcare services (15, 16).
Association between Age and HCV infection
Age is a known associated factor for HCV infection. In 
this study, there was significantly higher HCV infection 
in the older respondents (Mean=44.38, SD= 8.586) 
compared to the younger respondents (Mean=39.41, 
SD=9.319), t (210) = -3.964, p<0.001). These findings 
are similar to studies done in China whereby HCV 
infections is higher in the older age group of between 
50 and 59 years (25.85% of 2685) and lower in younger 
age group of between 0 and 9 years (0.93 % of 2685) 
(22). Another study done in Iran also reported higher 
HCV prevalence among people over 30 years old with 
a peak at 50 to 59 years old (3.8%) (23). Age is likely 
related to the natural history of the disease. A person 
will only seek medical attention after having signs and 
symptoms which are associated with chronicity of the 
disease. Furthermore, immunity factors deteriorate with 
increasing age.
Association between Education and HCV Infection
HCV infections vary depending on the level of education 
of the PWID. In this study, education and HCV infection 
was significantly associated (p = 0.022). Among 20 
respondents with lower education, 85.0% were HCV 
positive. Similarly, a cross-sectional study done in 
Yemen revealed that PWID with lower educational 
level was significantly associated with HCV infection (p 
<0.001) (24). It may be that those with lower education 
may have poorer health-related decision making which 
is crucial to ensure good compliance to medications and 
follow-up (25). For example, in lower educated PWID, 
they might face difficulty to understand the purpose of 
having safe injecting practices thus making them more 
susceptible to the blood-borne infections.     
Association between Duration of Injection in HCV 
Infection
The duration of injection was also significantly associated 
with HCV infections (p=0.01). This study findings are 
similar to a study conducted in New York that revealed 
that those who injected longer were at higher risk of 
being HCV seropositive whereby 80.4% of samples had 
been given their first injection by others (26). Research 
has shown that the longer duration of injecting leads to 
a greater risk of contracting HCV. According to McFall 
et al., 2017, in North West India, PWID with longer 
duration of injecting drugs are 70% more likely to have 
HCV infections (AOR per 10 years = 1.70, 95% CI = 
1.25-2.27) (4). The finding is also supported by a study 
done in China where they reported that those with longer 
duration of injecting drugs were 2.22 times more likely 
to be infected by HCV (AOR per 15 years = 2.22, 95% 
CI = 1.99 to 3.46) (27). Prolonged use of unsterile and 
contaminated needles and syringes will expose them to 
HCV infection and other related comorbidities.
Association between Frequency of Drug Injection and 
HCV Infection
In this study, there was significant association between 
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frequency of injection and HCV infection. Among106 
respondents with frequency of drug injection of more 
than once a day, a total 74.6% were HCV positive which 
is higher than those who inject less (i.e. around 34.4%). 
This finding is similar to a study done by Eckhardt et 
al 2017, where they concluded that the more frequent 
a person is injecting themselves, the more likely they 
are practising unsafe injections such as frequent usage 
of HCV contaminated needles or equipment shared by 
another person that may be HCV seropositive (26).
Association between Needle Sharing and HCV Infection
There was a significant association between needle 
sharing and HCV infection. Among 212 respondents 
with needle sharing, a total of 88.9 % were HCV positive, 
which is higher than those who were not (47.6%). This 
study was similar to a study done by McFall et al in 
2017, where they stated that the likelihood to get HCV 
infections among those who share needles was 2.46 
times more than those who does not (AOR = 2.46, CI = 
1.29-4.56) [4]. Similarly, in China, a study reported that 
the likelihood of having HCV infection among needle 
sharing PWID were 4 times more as compared those 
who does not (AOR 1.30, 95%CI 1.11 to 1.52) (27). This 
may be due to more exposure to contaminated needles, 
poor hygiene, unsafe repeated practices while sharing 
needles and equipment for self-inject.
Despite the availability of comprehensive harm reduction 
program in Malaysia which includes the Needle Syringe 
Exchange Program (NSEP) which is a program that 
provides free sterile needle syringes in exchange of the 
contaminated ones, the coverage is still low among 
the PWIDs. Other programs include the MMT program 
which is a program that uses opiate replacement by 
replacing heroin injection to oral methadone. Some 
studies have reported that the primary challenge to 
the NSEP implementation was police discrimination 
towards the PWID as they were labeled as criminals and 
not patients who have rights of access to health services 
(28, 29). In these studies, it is reported that PWIDs were 
often harassed and arrested by the police due to the fact 
that it is technically against the law to possess needles 
containing traces of illegal drugs (28, 29). Malaysia 
faces similar challenges, even though the NSEP has been 
a national agenda since the past decade. Majority of the 
clients have poor access to the harm reduction program 
due to lack of awareness on the NSEP among the police.
A local study reported that implementers have 
misinterpretations of the NSEP as they feel that the 
authorities are encouraging the PWIDs to continue 
injecting drugs by offering free sterile syringe and 
needles (29). Consequently, this has led to continued 
discrimination and stigmatization of the clients while 
managing them. 
Association between HIV and HCV Coinfections 
Several studies have reported that HIV infection was 
prevalent among PWIDs with HCV infection and 
mortality among the HIV-infected person was higher 
among those coinfected with HCV (30, 31). A study 
by Kakchapati et al. in 2017 stated that the PWIDs 
infected with HIV were significantly associated with 
HCV coinfections (p<0.001) (31). Similarly, this 
study identified that all 15 HIV-infected respondents 
were significantly associated with HCV coinfection 
(p=0.001). This may be due to the fact that both HCV 
and HIV share similar risk factors such as injecting drugs 
and sexual risk-taking behaviors (i.e. multiple partners 
and promiscuity). Therefore, preventive measures and 
treatment should be targeted to both HCV and HIV (32).
Age Encounter HCV Infection as The Predictors 
In this study, a year increase in age increases the odds 
of HCV infection by 1.07 times, while controlling for 
frequency (AOR=1.0, 95% CI=1.032-1.110). Thus, 
increasing age among PWID increases their likelihood 
of HCV infections. Similarly, a study done in Brazil 
concluded that with increase in age, the likelihood of 
becoming infected increases by 0.02% for each year 
of life (AOR = 1.02; 95% CI=1.01–1.04 (33). Another 
study in Afghanistan identified similar results whereby 
with a year of drug injecting, the risk of contracting HCV 
infection is at 4.72 higher (AOR= 4.72) (34).  This is 
probably due to the fact that older respondents were likely 
to have injected drugs for a longer period of time and 
therefore had more opportunities to become infected. 
Thus, if left uncontrolled, this may lead to prolonging 
of the duration of injections, exposing them to higher 
risk of developing HCV as well as higher morbidity 
and mortality among the PWIDs, especially due to liver 
complications. A previous study has identified that age 
is a predictor for the progression of liver fibrosis among 
HCV infected person whereby the study estimated that 
after 20 years of infection, 91% of them developed liver 
fibrosis without cirrhosis (95% CI=90-92%) (35). 
 
Frequency of Injections as the Predictor of HCV Infection
The other predictor on HCV infections in this study is 
the frequency of injections. The findings indicated that 
the respondents with more frequency in injecting drug 
were at six times more likely to be infected with HCV 
compared to those with less frequency of injections 
(AOR 5.975, 95%CI= 3.110-11.476). These finding is 
supported by a study done in China which found that 
injecting more than 4 times daily increases the odds 
of HCV infection by 1.36 times as compared to those 
injecting less than 4 times per day (AOR 1.36, 95% CI 
= 1.16 to 1.60) (27). Thus, people who frequently inject 
themselves have a higher risk of contracting HCV. This 
may be due to more exposure to contaminated needles, 
poor hygiene, and unsafe repeated practices while self-
injecting. 
From the findings, the associations and predictors of HCV 
infection among PWID were age, low education level, 
HIV infection, and high-risk behaviors related to drug 
injection including higher injection frequency, needle 
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sharing and longer duration of injecting drugs. The 
preventive measures should be targeted to the identified 
predictors and associations. It is recommended that the 
preventive measures be strengthened by enhancing 
health education among the younger generation on 
the harmful health impacts of taking illicit drugs so that 
they can make better decisions. PWIDs should be given 
appropriate health promotion materials that are easy to 
comprehend on the   HCV risk factors, complications, 
impact of HCV and HIV co-infections, safe practices of 
injecting such as needle sharing and prolonged injecting 
practices. They should be informed that registering 
themselves in the MMT program and reducing their 
frequency of injection may lower their risk of contracting 
HCV infections. 
For future research, the knowledge gained in this study 
can be utilized to enhance primary care-based HCV 
prevention programs. These programs may focus on 
individual behavioral change which are systematically 
introduced to minimize their high-risk behavior. For 
example, through development of a theory-based HCV 
intervention program among younger PWIDs and 
focusing on strengthening the harm reduction program 
to prevent further drug injections through opiate 
substitution therapy. The other recommendation is that 
this study can be expanded to a bigger scale to produce 
results which could represent the whole population. 
This study provides baseline information regarding the 
status and factors associated with HCV infection among 
PWID in Negeri Sembilan as this is the first study on 
HCV infection and its associated factors among PWID. 
The data presented in this study would be useful for 
future studies, especially for the purpose of making 
comparisons. Additionally, the tool used in this study to 
measure the factors associated with HCV among PWID 
can be utilized in future studies as it has been validated 
and shown to be reliable. However, this is a cross-
sectional study which can only study the relationship 
and associations between independent variables and 
dependent variable. The temporal relationship between 
the causative factors and dependent variables cannot 
be determined as this study only looked at one point 
in time. Furthermore, this study cannot represent the 
entire population of PWIDs in Negeri Sembilan as only 
selected clinics were chosen during data acquisition.
CONCLUSION
The predictors of HCV infection are older age [AOR 1.07, 
95% CI (1.032, 1.110), p<0.001] and higher frequency 
of injections [AOR 5.98, 95% CI (3.110, 11.476), 
p<0.001]. In this study, PWIDs with higher age are more 
likely to have higher risk exposure to HCC. This may be 
due to the prolonged and repetitive behaviour of self-
injecting, apart from being less educated, resulting in 
the lack of understanding on the safe way of self-inject. 
Furthermore, they may be less aware of the available 
health resources in terms of harm reduction which leads 
to delay in treatment, despite the existence of various 
prevention and control measures for HCV. 
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